Skip to main content

Atrium Mesh Lawsuits: Monthly Status Conference on March 8

Atrium Mesh Lawsuits: Monthly Status Conference on March 8

Atrium Mesh Lawsuits: Monthly Status Conference on March 8

Introduction

The Atrium C-Qur Hernia Mesh lawsuits centralized in 2017 under MDL 2753 in the U.S. District Court for the District of New Hampshire include all types of C-Qur line of polypropylene surgical mesh. Hon. Judge Landya B. McCafferty is presiding over the Atrium Medical Corp. litigation where more than 20 lawsuits are pending for trial.

The court convened a regular monthly status conference on March 8 to discuss bellwether case management order, plaintiffs jurisdictional requests, deposition dates for plaintiffs’ requested Rule 30(b)(6) deponent, defendants’ privilege log, and location of the deposition of Reinhard Mayer primarily.

Plaintiffs allege that the C-Qur mesh causes an inflammatory response that may result in improper fixation, bowel adhesions, and other severe complications. Claims also include that Atrium failed to provide appropriate safety warnings to the medical community and patients in spite of being aware of the alleged design defects.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ 100% FREE — 60 mins Legal Transcription and 2 Demand Letters!                 
🔒 No AI. No Risk. No Contract. 100% HIPAA-Compliant, Done by Attorneys & Doctors.

Only 06 Slots left for Law Firms—Offer Ends Sep 30!